Streamlining biosimilar development based on 20 years' experience
{{output}}
Introduction: Biosimilar clinical programs could be streamlined by prudent application of improved methodologies and knowledge accumulated over the past 20 years. This review focuses on whether complex comparative efficacy trials... ...
